Deep Bio’s AI Model for Prostate Cancer Assessment Validated by Researchers
admin@pathologynews.com2024-08-06T14:58:26+00:00Deep Bio Inc., a leader in AI-driven digital pathology solutions, announced the publication of an external validation study for its DeepDx Prostate AI algorithm, conducted by Stanford Medicine. The study, titled “External Validation of an Artificial Intelligence Model for Gleason Grading of Prostate Cancer on Prostatectomy Specimens,” was published in the British Journal of Urology International.










